Zhang et al. (2013)

Summary of novel genes

Entity Tier 1 genes Tier 2 genes Tier 3 genes
DLBCL 11 8 272
--- config: sankey: showValues: true linkColor: target width: 600 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, New Tier 1, 11 New Tier 1, DLBCL Tier 1, 11 This study, New Tier 2, 8 New Tier 2, DLBCL Tier 2, 8 This study, New Tier 3, 272 New Tier 3, DLBCL Tier 3, 272 All other DLBCL studies, DLBCL Tier 1, 114 All other DLBCL studies, DLBCL Tier 2, 202 All other DLBCL studies, DLBCL Tier 3, 115

Novel genes reported in this study

Tier 1

New gene DLBCL tier
ARID1A 1
DTX1 1
FBXW7 1
HIST1H2BK 1
KLHL14 1
KMT2C 1
LRRN3 1
MTOR 1
NOTCH2 1
OSBPL10 1
RHOA 1

Tier 2

New gene DLBCL tier
ANKRD17 2
BTBD3 2
DDX10 2
NF1 2
PIK3CD 2
PIK3R1 2
SETD2 2
SMEK1 2

Tier 3

New gene DLBCL tier
ABCA3 3
ABCA4 3
ACE 3
ACSM3 3
ACSS2 3
ACSS3 3
ACTN1 3
ADAM2 3
ADAMTS15 3
ADH7 3
AFAP1L2 3
AHR 3
AKAP9 3
ALAS1 3
ALDH1L2 3
AMAC1 3
AMIGO3 3
AMPH 3
ANK2 3
ANKRD44 3
ANTXR1 3
AP1G2 3
APBB1 3
APC 3
APOA5 3
APP 3
ATIC 3
ATP10A 3
ATP1A2 3
ATP2A3 3
B4GALNT2 3
BAZ1A 3
BCAT2 3
BLM 3
BMPR1A 3
BRCA2 3
BRD4 3
BSCL2 3
BTAF1 3
C9 3
CAD 3
CAPN5 3
CAPN7 3
CCDC132 3
CCDC46 3
CCDC97 3
CCNF 3
CDC123 3
CDH10 3
CDH7 3
CDK3 3
CECR1 3
CELSR2 3
CHD3 3
CHRM5 3
CIC 3
CNGA4 3
CNOT6 3
CNP 3
CNTN6 3
COL5A2 3
CORO2A 3
CORO7 3
CRELD2 3
CRTC3 3
CST7 3
CTNNA3 3
CYP24A1 3
CYP2C18 3
DDB1 3
DIAPH3 3
DIP2B 3
DLGAP1 3
DMXL1 3
DOCK2 3
DOLK 3
DSC2 3
DSCAML1 3
DSG2 3
DSP 3
DUOXA2 3
DUPD1 3
DYNC1H1 3
DYNC1I1 3
ECGF1 3
EPHA3 3
EPHA5 3
EPHA7 3
ERBB3 3
ERN2 3
ETNPPL 3
EXTL3 3
FAM62C 3
FANCD2 3
FGD3 3
FGFR1 3
FIGN 3
FLNC 3
FMO2 3
FRMPD1 3
GABRG1 3
GCN1L1 3
GJA8 3
GJB4 3
GOPC 3
GPD2 3
GPR133 3
GPR15 3
GREM2 3
GRIA2 3
GRM5 3
H6PD 3
HACE1 3
HCK 3
HIPK3 3
HIST1H4I 3
HK3 3
HNRNPR 3
HSF2 3
IDH1 3
INSC 3
INTS6 3
IQGAP1 3
IQUB 3
ITGA2 3
ITGA8 3
ITGB3 3
JAG1 3
JAKMIP2 3
KCNA3 3
KCNAB3 3
KCNJ6 3
KCNT2 3
KDR 3
KIF21B 3
KIT 3
KLB 3
KLC3 3
KLF4 3
KRT6A 3
LEPREL1 3
LIFR 3
LILRA2 3
LIN7C 3
LPHN2 3
LRAP 3
LRIG3 3
LRP1 3
LRP10 3
LRP1B 3
LRP3 3
LYST 3
MARCHF7 3
MBL2 3
MED13L 3
MIB1 3
MN1 3
MORC2 3
MPL 3
MTMR3 3
MYL7 3
MYO5C 3
MYRIP 3
NDUFS1 3
NELL2 3
NFIB 3
NFX1 3
NGFR 3
NIPBL 3
NLGN2 3
NLRP7 3
NPHP1 3
NPY2R 3
NRXN2 3
NSD1 3
NSD2 3
ONECUT1 3
PADI1 3
PAPPA2 3
PBX1 3
PCCB 3
PCDE1C 3
PCDH7 3
PCDHB1 3
PCDHB15 3
PCDHB3 3
PCDHB5 3
PCDHGA2 3
PDE1C 3
PDGFRA 3
PDIA2 3
PDZRN3 3
PDZRN4 3
PLA2G4B 3
PLEKHA7 3
PNLIPRP1 3
PNPT1 3
POLE 3
PPARGC1A 3
PPWD1 3
PRDM16 3
PRKCB1 3
PRKCQ 3
PROS1 3
PRSS7 3
PTPN14 3
PTPRF 3
PTPRT 3
PXK 3
RAB3GAP1 3
RAPGEF2 3
RBM15B 3
RELN 3
RFC1 3
RGS1 3
ROR2 3
RSL1D1 3
RUNDC1 3
RYR1 3
SAPS3 3
SCYL1 3
SEMA3A 3
SEMA3D 3
SEMA5A 3
SERINC2 3
SH3PXD2B 3
SHMT2 3
SIGLEC10 3
SLC16A7 3
SLC4A8 3
SLC5A1 3
SLC9A5 3
SOX6 3
SPEG 3
SPTBN1 3
ST8SIA3 3
SULF2 3
TAF1L 3
TAF4B 3
THBS4 3
TIMM50 3
TLN2 3
TMC1 3
TMEM161A 3
TMEM16E 3
TMEM63A 3
TPRKB 3
TRIM37 3
TRIP11 3
TRRAP 3
TSC2 3
TSHZ2 3
UHRF1BP1L 3
UNC13B 3
UQCRC1 3
VPS13A 3
WDR65 3
WDR66 3
WDR67 3
WIF1 3
WNK4 3
WT1 3
XDH 3
ZIC4 3
ZNF354A 3
ZNF366 3
ZNF439 3
ZNF474 3
ZNF700 3
ZNF790 3
ZNF91 3
ZP1 3

Details

Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. “Genetic Heterogeneity of Diffuse Large B-cell Lymphoma.” Proceedings of the National Academy of Sciences of the United States of America 110: 1398–1403. https://doi.org/10.1073/pnas.1205299110.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.